The Future of
Medical AI
Delivered Weekly
Curated research insights for clinicians and patients. No hype. Just evidence.
Modifiable risk factors drive a large share of the global cancer burden
Approximately 40% of global cancer cases are linked to lifestyle factors, highlighting the urgent need for preventive measures to reduce cancer risk.
Why Medical Professionals Choose Mednosis
We cut through the noise to deliver research that actually matters
Built for Clinicians
Technical notes include study design, sample sizes, confidence intervals, and key limitations
Patient-Friendly
Every article includes plain language explanations your patients can understand
Zero Hype Guarantee
Practice impact ratings tell you exactly how close research is to clinical reality
Latest Research
First-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial
A structure-based mRNA vaccine for Nipah virus in healthy adults: a phase 1 trial
Where AI can make the biggest impact in healthcare
How Your Virtual Twin Could One Day Save Your Life
Pragmatic by design: Engineering AI for the real world
The Healthcare AI Strategy Of China
Get smarter about medical AI every week
Join clinicians and researchers staying ahead of the curve
Trending This Week
Research getting the most attention
First-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial
A structure-based mRNA vaccine for Nipah virus in healthy adults: a phase 1 trial
Developing and evaluating a chatbot to support maternal health care
Find What Matters to You
Filter research by how close it is to clinical practice
Browse by Specialty
Find research relevant to your field
Never Miss a
Breakthrough
Get curated AI in medicine research delivered weekly. No spam, unsubscribe anytime.
AI in Medicine 101
Learn how to read medical AI research, spot red flags in hype-y articles, and ask the right questions about new technologies.